Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
about
Oncothermia with Chemotherapy in the Patients with Small-Cell Lung CancerA review of clinical practice guidelines for lung cancerLesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs.High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers.Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer.Benefit from ifosfamide treatment in small-cell lung cancer: A meta-analysis.Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive casesEffects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study.Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system.Completeness of TNM staging of small-cell and non-small-cell lung cancer in the Danish cancer registry, 2004-2009Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues OncologuesHigh-fidelity of non-small cell lung cancer xenograft models derived from bronchoscopy-guided biopsies.Oral treatment with etoposide in small cell lung cancer - dilemmas and solutions.Progress in the management of limited-stage small cell lung cancer.Management of small cell lung cancer: recent developments for optimal care.Long-term survival in small cell lung cancer: a case report and review of the literature.Immunotherapy prospects in the treatment of lung cancer and mesothelioma.KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer.N-acetylglucosaminyltransferase V modulates radiosensitivity and migration of small cell lung cancer through epithelial-mesenchymal transition.Long survival of a small-cell lung cancer patient who received maintenance chemotherapy with irinotecan.Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy.Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer.Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer.Surgical treatment of early stage small cell lung cancer.The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
P2860
Q21284759-1CECD26A-69CE-4190-8630-481278D3A54FQ26999236-6C1A95B6-5385-4A97-9D65-F0C8051FC364Q33437893-2161F013-D459-4504-A999-EA1EA1D251CFQ33566790-A8E9A479-5502-4757-B092-756EEC507D45Q34092436-111FADA5-86E8-40C9-A131-9E6987091099Q35179886-61080270-C3DB-40D3-A165-E001FEDA6A1BQ35595219-CE2D5478-9A6D-4CFE-B1A8-E54B1AF074F0Q35598608-0010C926-4531-4900-9E37-EAD1A2CA8F29Q35713556-7C732829-13B5-4FAC-8842-93B7D656ADBDQ36194013-617CC85A-02BC-4052-9D11-D3E957710B7CQ36206880-F4DC5106-CD50-499E-BCD5-A8F9AB577DD3Q36477716-EA4E2D89-7A26-4FFE-B0CC-A931F62B43EDQ36613874-34BBB004-56AA-4313-B3C8-F9930B949597Q37626969-07E3A0EE-C945-4BB7-B83C-4EA7D8D36CD9Q37987205-EFF9A116-BAE5-4A3B-A9F6-80A714D30596Q38206270-0CF00B8A-A5B4-4292-B3F2-F0F7FE29A06BQ38390104-6871B1BD-0AFB-4224-9210-9AD373E63ABDQ38745227-31E1961B-B825-4E74-BE62-0BED525A78DEQ38842197-7E3011F6-FA1D-4A8F-8BE9-E9ED95382495Q41861664-D51EB431-D9ED-4E18-8986-15AE6C3D591AQ45924371-C89F2AC4-8A0A-4BF5-9900-C1C4B8132B50Q47107751-7FC9242A-A824-4A44-981D-D67CF6293152Q50502921-99BC2725-72F4-465B-8FF8-F1BDB43CD32AQ50882852-70DD3086-8DCC-4EC6-BBFB-EB6F105484EDQ54388835-933C5C8B-B569-4777-A671-5CDD6C7EF569Q57272149-D26263C9-2412-475C-8607-027EAA39CED5
P2860
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Small-cell lung cancer: ESMO C ...... osis, treatment and follow-up.
@en
Small-cell lung cancer: ESMO C ...... osis, treatment and follow-up.
@nl
type
label
Small-cell lung cancer: ESMO C ...... osis, treatment and follow-up.
@en
Small-cell lung cancer: ESMO C ...... osis, treatment and follow-up.
@nl
prefLabel
Small-cell lung cancer: ESMO C ...... osis, treatment and follow-up.
@en
Small-cell lung cancer: ESMO C ...... osis, treatment and follow-up.
@nl
P2093
P356
P1433
P1476
Small-cell lung cancer: ESMO C ...... nosis, treatment and follow-up
@en
P2093
ESMO Guidelines Working Group
M Pijls-Johannesma
M Sørensen
P304
P356
10.1093/ANNONC/MDQ172
P478
21 Suppl 5
P577
2010-05-01T00:00:00Z